Most lately, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent regions as classical opioid receptors, it binds to the big selection of endogenous opioids. In contrast to most opioid receptors, this receptor functions to be a scavenger and doesn't a